Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating safety and efficacy of buparlisib (BKM120) in patients with metastatic non-small cell lung cancer; results posted i…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients [Phase 4]
Phase 4 trial evaluating CYP3A4 and CYP1A2 phenotyping to tailor Sunitinib or Erlotinib therapy in cancer patients, including non-small cell…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations [Phase 4]
Phase 4 study results reported for erlotinib (Tarceva) as first-line therapy in patients with locally advanced or metastatic EGFR-mutant non…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating chidamide in combination with carboplatin and paclitaxel for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2016-02-01Clinical Trial Update: Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC [Phase 2]
A Phase 2 clinical trial evaluating cellular immunotherapy in combination with chemotherapy for patients with Stage IV Non-Small Cell Lung C…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 randomized, double-blind trial comparing erlotinib with pazopanib versus erlotinib with placebo in previously treated advanced non-s…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy [Phase 2]
A Phase 2 study of belotecan (Camtobell Inj) given on a weekly schedule in patients with non-small cell lung cancer who were previously trea…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring [Phase 3]
A Phase 3 study (CESAR) evaluating therapeutic drug monitoring for paclitaxel in non-small cell lung cancer has completed.
-
FDA approval · 2016-01-26FDA Approved: GEMCITABINE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' supplemental application for gemcitabine hydrochloride (gemcitabine), enabling continued producti…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating imetelstat as maintenance therapy after induction chemotherapy in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: CTP Imaging of Lung Cancer
A clinical trial evaluating CTP imaging in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients [NA]
Clinical trial update on transcutaneous electrical acupoint stimulation for non-small cell lung cancer; the current status of the trial is u…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC [Phase 2]
This clinical trial update reports Phase 2 results for the BEACON study evaluating bevacizumab in combination with chemotherapy for operable…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer
This document summarizes an update on a non-interventional trial of erlotinib (Tarceva) for metastatic non-small cell lung cancer, with resu…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib [Phase 2]
A Phase 2 trial update reports results for dasatinib in advanced non-small cell lung cancer that progressed after Erlotinib or Gefitinib.
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene [Phase 2]
Phase II trial assessing whether radiographic response to the EGFR inhibitor gefitinib correlates with EGFR mutations in non-small cell lung…
-
CLINICAL_TRIALS other · 2016-01-22Clinical Trial Update: Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. [Phase 2]
A Phase 2 trial evaluating neoadjuvant afatinib for early-stage non-small cell lung cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
The document reports an update on a completed clinical trial examining circulating tumor cells in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating gefitinib in combination with everolimus for stage IIIB/IV or recurrent non-small cell lung cancer. R…
-
CLINICAL_TRIALS research · 2016-01-21Clinical Trial Update: Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)
Update on a real-time fluorescent PCR kit for quantitative detection of EGFR mutations, including sensitizing and resistance mutations, in n…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing docetaxel plus ramucirumab versus docetaxel plus placebo in metastatic non-small cell lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1) [Phase 1]
Phase 1 dose-escalation trial of oral BIBF 1120 (nintedanib) combined with vinorelbine in elderly patients with advanced non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]
Phase 1 safety study of an antisense product in multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial (TORCH) comparing Tarceva (erlotinib) with chemotherapy for advanced non-small cell lung cancer has completed.
-
EMA withdrawal · 2016-01-14EMA Withdrawn: Nivolumab BMS (nivolumab) — Bristol-Myers Squibb Pharma EEIG
EMA withdrawn nivolumab (BMS) for non-small cell lung carcinoma; product withdrawal decision in 2015.